health
VectorY broadens global PIONEER-ALS clinical trial cohort

VectorY Therapeutics has expanded the study size for its ongoing, global Phase I/II PIONEER-ALS clinical trial of VTx-002 for ALS. The post VectorY broadens global PIONEER-ALS clinical trial cohort appeared first on Clinical Trials Arena .
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories

New test in Nottingham diagnoses MS without needle procedure
BBC

Devon and Cornwall families plea for more help in dementia battle
BBC

Middlesbrough FC Foundation cancer fitness group 'saved me'
BBC

Girl,12, campaigns for healthier hospital food
BBC

'A bleak picture': The Plymouth wards where men are facing premature death
Plymouth Live